Oxford Nanopore Technologies, a publicly owned company headquartered in the United Kingdom, was founded in 2005. The company develops and sells nanopore sequencing products for the direct, electronic analysis of single molecules, including its portable DNA sequencer, MinION. It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.